BioVie's groundbreaking drugs inflammation, aging, and liver disease

By Proactive Investors / December 18, 2025 / www.youtube.com / Article Link


BioVie Inc CEO Cuong Do joined Proactive to share updates on the company's lead drug candidates, Bezisterim and BIV201.

Recent News

Bank of Japan boosts rates, continuing an unwinding carry trade
December 22, 2025 / www.canadianminingreport.com

Gold stocks outperform equity market slide
December 22, 2025 / www.canadianminingreport.com

Silver inventories rebound in UK, output from major producers rises
December 15, 2025 / www.canadianminingreport.com

Silver's three-month outperformance continues
December 15, 2025 / www.canadianminingreport.com

Silver & Copper Supply Distortions Continue
December 08, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok